Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering K-Dur Settlement With AHP Under Investigation By FTC

Executive Summary

A settlement between Schering-Plough and ESI Lederle regarding patent litigation surrounding Schering's K-Dur is among cases being investigated by the Federal Trade Commission for potential antitrust violations.
Advertisement

Related Content

FTC K-Dur Suit Would Allow Andrx Generic Launch; FDA Could Act First
FTC K-Dur Suit Would Allow Andrx Generic Launch; FDA Could Act First
K-Dur generic
K-Dur generic
Ivax Generic Zoloft Exclusivity Will Be Unaffected By New FDA Guidance
FTC Hytrin Order Clears Path For Four Generics; Cardizem CD Case Filed
FTC Hytrin Order Clears Path For Four Generics; Cardizem CD Case Filed
Bristol Glucophage Price Increase Highlighted In Families USA Report
Advertisement
UsernamePublicRestriction

Register

PS035828

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel